hyperglycemia state causing polydipsia, polyphagia and polyuria.
Thomas Cawley first reported the case of diabetes. Paul Langerhan's (1847-1888) first discovered the distinct tissue in the pancreas called as islet's of Langerhan's. Banting and John Macleod were awarded Nobel Prize in 1923 for the "Discovery of Insulin". 1 As per the available data, about 285 million people had diabetes till 2010 with 90% having type-2 Diabetes. 2 International Diabetes Federation estimate 381 million people having diabetes in 2013 and by 2030, the incidence will be doubled. 3 In India, 7.1% of India's adult population is affected with diabetes i.e. nearly 62 million people are affected. The high incidence is due to combination of genetic susceptibility plus adoption of high calorie diet and sedentary life style by India's growing middle class. 4 As per WHO, the diagnosis of diabetes is done by oral glucose tolerance test. 5 Diabetes can be classified into the following general categories: 6 • Type 1 diabetes (due to β-cell destruction, usually leading to absolute insulin deficiency) 8 Over the period of time the metabolic dysregulation associated with diabetes mellitus causes secondary pathophysiological changes in multiple organs like heart, blood vessels, eyes, kidney and nerves resulting in various complications. 9 Diabetes mellitus is an established leading known cause of neuropathy in the world. 10 Neuropathy is a most common complication and greatest source of morbidity and mortality in diabetic patients. 11 It is estimated that the prevalence of neuropathy in a diabetic patient is approximately 20%. 10 Metformin is recommended as initial therapy after life style modification for type-2 diabetes. 11, 12 In America metformin was approved in 1996 and since then its use is increased dramatically following UKPDS study, when it was found to be effective in decreasing diabetes related chronic complications and mortality in type-2 obese patients. 13 Metformin's best-known side effect i.e. metabolic acidosis almost never occur if metformin is used in appropriate manner. Other common side effect of metformin is gastrointestinal related and is overcome by initiating the drug at low dose or by giving the drug after the meal with sustained release preparations. Metformin use has been unequivocally demonstrated as the prime factor associated with vitamin B12 deficiency among patients with type 2 Diabetes mellitus. [21] [22] [23] [24] However, a common potential interaction of metformin with vitamin B-12 is well documented but is poorly studied by the physicians who prescribe metformin to their diabetic patients. Since vitamin B-12 deficiency is common among vegan population as compared to population consuming food of animal origin (meat, fish and dairy products).
But in this article, it has been studied that metformin cause vitamin B-12 deficiency even in non-vegetarian population. So, a routine screening for vitamin B-12 level must be done in patients receiving metformin for treatment of type-2 Diabetes. All patients satisfying inclusion and exclusion criteria were included in study. This was a cross sectional study.
METHODS

This
All patients were subjected to a detailed history and thorough clinical examination including neurological examination after obtaining his/her informed consent.
Investigations
Fasting and post prandial blood sugar, serum creatinine, blood urea, complete blood count, HbA1C, TSH, Serum vitamin B12 levels. Normal range of vitamin B12 = 187-887 pg/mL (as per Institute laboratory).
Statistical analysis was done by SPSS version 22.0 and p value was obtained.
RESULTS
Total 93 patients were included in the study who satisfied the inclusion and exclusion criteria.
In this study, mean age was 51.24 years with minimum age 39 years and maximum age 60 years.
Out of total 93 patients, 51 patients (54.84%) were male and 42 patients (45.16%) were female (Figure 1 In the present study, minimum dose of Metformin was 1.00 gram and maximum dose of metformin was 2.55 grams with average of 1.84 grams (Figure 4 ).
In the present study vitamin B12 deficiency was found in 38 patients (40.86%) out of total 93 patients.
Out of 38 patients with vitamin B12 deficiency, 25 patients were non-vegetarian and 13 patients were vegetarian. Among non-vegetarian patients, vitamin B12 deficiency was found in 35.71% (25 out of 70) patients and among vegetarian patients vitamin B12 deficiency was found in 56.52% (13 out of 23) patients but the association was statistically not significant (Table 1) . Although vitamin B12 deficiency was more common among vegetarian than non-vegetarian patients of study population, the difference was considered to be statistically not significant by paired t test (p value=0.532).
DISCUSSION
In the present study vitamin B12 deficiency was found in 40.86% patients which was comparable to study done by Qureshi S et al. 25 Among vegetarian patients, vitamin B12 deficiency was found in 56.52% patients which was much higher than normal population and 35.71% patients had vitamin B12 deficiency among non-vegetarian patients. High incidence of vitamin B12 deficiency among nonvegetarian patients favor that use of Metformin was associated with vitamin B12 deficiency. Morar O et al, found vitamin B12 deficiency in 33% patients of diabetes mellitus on metformin therapy for more than 18 months. 26 Ting et al showed an increased risk of vitamin B12 deficiency associated with duration of metformin use and dose of metformin and found these parameters to be high risk factors for developing B12 deficiency. 27 In the present study only those patients were included who were on metformin for more than 5 years and average duration of treatment was 9.49 years.
CONCLUSION
On the basis of the present study we conclude that Vitamin B12 deficiency is common in patients of diabetes mellitus on prolonged Metformin based OHA therapy. Deficiency is more common among vegetarian population on prolonged metformin therapy than nonvegetarian population but the difference is not statistically significant which is more in favor of Metformin associated Vitamin B12 deficiency in nonvegetarian population. Hence, we recommend routine screening for vitamin B12 deficiency in diabetes patients on Metformin based OHA therapy.
Due to small data and demographic variation among different regions of world, more research with greater number of subjects is needed to test this hypothesis. 
